In addition, it appears to provide protection after a single shot, whereas SARS-CoV-2 vaccines such as the one that Pfizer and BioNTech have developed require two doses 1 month apart. “This has important logistical implications, in particular for countries with a less advanced medical system,” explains Prof.
Johan Neyts, from the Rega Institute at KU Leuven in Belgium. Prof. Neyts is one of the virologists who led the research. Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.Prof.
Neyts also believes that the vaccine may offer long lasting immunity against COVID-19. “It could therefore be an ideal candidate for repeat vaccinations when immunity.